Corteva Inc

Corteva, Inc. is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to food supply. The firm operates through the following segments: Seed and Crop Protection. The Seed segment is engaged in the developing and supplying of advanced germplasm and traits that produce yield for farms. The Crop Protection segment is involved in offering the global agricultural input industry with products that protect against weeds, insects, other pests, and diseases, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Corteva Inc reports robust 2022 performance and targets growth

Corteva Inc's strong 2022 performance and strategic acquisitions position it well for growth.
Challenges like lower Crop Protection volumes and cost headwinds are being addressed proactively.
Opportunities lie in new product growth, market assumptions for 2023, and achieving long-term targets.
Overall, Corteva Inc remains focused on innovation, margin expansion, and delivering value to shareholders.

Corteva excels in Q1, raises guidance amid market challenges

Corteva's Q1 performance reflects strong growth and margin expansion, with raised full-year guidance signaling confidence in future prospects.
Challenges like pricing headwinds and volume declines in certain regions are being addressed strategically, with opportunities in frontier markets and value creation initiatives.
Overall, Corteva's strategic choices, market share gains, and product innovation position the company well for continued growth and differentiation in the industry.
Investors should monitor Corteva's progress in addressing challenges and capitalizing on opportunities to achieve its ambitious 2025 targets.

Corteva reports growth in Q2 2023 despite challenges ahead

Corteva's Q2 2023 showed growth in seed business but challenges in Crop Protection, leading to adjusted guidance for the year.
Confidence in 2025 financial targets remains strong, with optimism for growth and margin expansion in 2024 driven by new products and cost efficiencies.
Market pressures and customer adjustments impacted earnings cadence, with opportunities seen in gene editing, seed pricing, and future growth drivers.
Improvements expected in free cash flow conversion, destocking challenges, and detailed plans for 2024 growth drivers and financial targets.

Corteva Inc reports robust Q3 performance, eyes growth opportunities

Corteva Inc's Q3 2023 earnings call showcased strong performance and strategic focus on margin expansion and value creation. Despite challenges in destocking and cash flow shortfalls, the company remains optimistic about global demand, margin growth, and operational efficiencies. Corteva's proactive approach to optimizing operations and product portfolio positions it for growth and shareholder returns.

Corteva Inc reports solid 2023 performance amidst Latin America challenges

Corteva's 2023 performance met expectations with strong EBITDA growth and margin expansion.
Challenges in Latin America, especially Brazil, were offset by promising long-term growth opportunities.
The company's strategic focus on high-value products and services positions it well against generic competition.
Overall, Corteva remains committed to providing value through technology and service to farmers.

Corteva Inc meets Q1 expectations, focuses on Enlist technology growth

Corteva Inc's Q1 2024 performance met expectations, with a focus on Enlist technology and biologicals driving growth.
Challenges include volume growth issues in Crop Protection and cost increases in Seed business.
Opportunities lie in new product focus, pricing strategy, and market improvements anticipated in the second half.
Overall, Corteva remains competitive, with a strong financial framework for 2025 and a commitment to engaging investors.

Corteva Inc meets Q3 expectations, eyes record 2025 demand

Corteva's Q3 performance aligned with expectations, emphasizing cost savings and future earnings growth prospects for 2025.
Strategic leadership changes and market assumptions signal a proactive approach to capitalize on record demand and drive business performance.
Challenges include sales declines, cost management, and product performance, while opportunities exist in innovation, investor engagement, and market optimization.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Corteva, Inc. engages in the provision of seed and crop protection solutions, which engages in the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment involves the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

Scotts Miracle-Gro

These two companies operate in different parts of the global agriculture industry. Which is a better choice for investors today?

Better Buy: Scotts Miracle-Gro vs. Corteva Agriscience

The world's second largest agrochemical name is finally an independent company.

Is Corteva Agriscience a Buy?

Corteva, Inc. was spun off from Dupont de Nemours, fka DowDuPont, on June 1, 2019.  We have analyzed what is available publicly on the stock.

Corteva, Recently Spun Off, Lacks Clear Value

News for Corteva Inc Stock (CTVA)